1,407
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Properties of SF-6D when longitudinal data from 16,398 spine surgery procedures is applied to 9 national SF-6D value sets

, &

  • Abellan Perpinan J M, Sanchez Martinez F I, Martinez Perez J E, Méndez I. Lowering the ‘floor’ of the SF-6D scoring algorithm using a lottery equivalent method. Health Econ 2012; 21(11): 1271–85.
  • Angst F, Aeschlimann A, Angst J. The minimal clinically important difference raised the significance of outcome effects above the statistical level, with methodological implications for future studies. J Clin Epidemiol 2017; 82: 128–36.
  • Brazier J E, Roberts J. The estimation of a preference-based measure of health from the SF-12. Med Care 2004; 42(9): 851–9.
  • Brazier J, Usherwood T, Harper R, Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol 1998; 51(11): 1115–28.
  • Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002; 21(2): 271–92.
  • Brazier J E, Fukuhara S, Roberts J, Kharroubi S, Yamamoto Y, Ikeda S, Doherty J, Kurokawa K. Estimating a preference-based index from the Japanese SF-36. J Clin Epidemiol 2009; 62(12): 1323–31.
  • Brazier J E, Mulhern B J, Bjorner J B, Gandek B, Rowen D, Alonso J, Vilagut G, Ware J E, SF-6Dv2 International Project Group. Developing a new version of the SF-6D health state classification system from the SF-36v2: SF-6Dv2. Med Care 2020; 58(6): 557–65.
  • Carreon L Y, Berven S H, Djurasovic M, Bratcher K R, Glassman S D. The discriminative properties of the SF-6D compared with the SF-36 and ODI. Spine (Phila Pa 1976) 2013; 38(1): 60–4.
  • Craig B M, Pickard A S, Stolk E, Brazier J E. US valuation of the SF-6D. Med Decis Making 2013; 33(6): 793–803.
  • Cruz L N, Camey S A, Hoffmann J F, Rowen D, Brazier J E, Fleck M P, Polanczyk C A. Estimating the SF-6D value set for a population-based sample of Brazilians. Value Health 2011; 14(5 Suppl. 1): S108–S14.
  • EuroQol Group. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy 1990; 16(3): 199–208.
  • Fayers P M, Machin D. Quality of life: The assessment, analysis and reporting of patient-reported outcomes. 3rd ed. Chichester: Wiley; 2016.
  • Ferraz M B, Nardi E P, Campolina A G. A comparison of UK and Brazilian SF-6D preference weights when applied to a Brazilian urban population. Value Health Reg Issues 2019; 20: 21–7.
  • Ferreira L N, Ferreira P L, Pereira L N, Brazier J, Rowen D. A Portuguese value set for the SF-6D. Value Health 2010; 13(5): 624–30.
  • Jonker M F, Donkers B, de Bekker-Grob E W, Stolk E A. Advocating a paradigm shift in health-state valuations: the estimation of time-preference corrected QALY tariffs. Value Health 2018; 21(8): 993–1001.
  • Kharroubi S A, Beyh Y, Harake M D E, Dawoud D, Rowen D, Brazier J. Examining the feasibility and acceptability of valuing the Arabic version of SF-6D in a Lebanese population. Int J Environ Res Public Health 2020; 17(3): 1037.
  • Lam C L K, Brazier J, McGhee S M. Valuation of the SF-6D health states is feasible, acceptable, reliable, and valid in a Chinese population. Value Health 2008; 11(2): 295–303.
  • McGhee S M, Brazier J, Lam C L K, Wong L C, Chau J, Cheung A, Ho A. Quality-adjusted life years: population-specific measurement of the quality component. Hong Kong Med J 2011; 17(Suppl. 6): 17–21.
  • Norman R, Viney R, Brazier J, Burgess L, Cronin P, King M, Ratcliffe J, Street D. Valuing SF-6D health states using a discrete choice experiment. Med Decis Making 2014; 34(6): 773–86.
  • Rizzo M L. Statistical computing with R. 2nd ed. Boca Raton, FL: CRC Press Taylor & Francis Group; 2019.
  • Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan 2006; 21(5): 402–8.
  • Strömqvist B, Fritzell P, Hägg O, Jönsson B, Sandén B, Swedish Society of Spinal Surgeons. Swespine: the Swedish spine register: the 2012 report. Eur Spine J 2013; 22(4): 953–74.
  • Thygesen L C, Ersbøll A K. When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol 2014; 29(8): 551–8.
  • Van Dongen J M, Jornada Ben A, Finch A P, Rossenaar M M M, Biesheuvel-Leliefeld K E M, Apeldoorn A T, Ostelo R W J G, van Tulder M W, van Marwijk H W J, Bosmans J E. Assessing the impact of EQ-5D country-specific value sets on cost-utility outcomes. Med Care 2021; 59(1): 82–90.
  • Ware J E Jr, Sherbourne C D. The MOS 36-item short-form health survey (SF-36), I: Conceptual framework and item selection. Med Care 1992; 30(6): 473–83.